Rowland Thomas Andrew sold ANIP
May 12, 2026 · Form 4 insider transaction
Rowland Thomas Andrew sold 459 shares of ANI Pharmaceuticals, Inc. at $79.21 per share, a transaction worth $36.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
459
Price
$79.21
Total value
$36.4K
InsiderRowland Thomas Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 12, 2026
Filing dateMay 13, 2026
Shares owned after38,271
OwnershipDirect
10b5-1 planNo
AmendedNo